In der vorliegenden Studie wurden Knochenmarkpräparate von insgesamt 57 Patienten berücksichtigt, wobei 24 keine systemische Mastozytose, und 33 eine systemische Mastozytose in den konventionellen Färbungen aufwiesen.
Schulz, T. (Thomas)
core
Clonal Mast Cell Disorders and Mutation Profile in Adults Initially Presenting with Mast Cell Activation (Anaphylaxis) versus Non-Anaphylactic Presentations: A Joint Allergy-Hematology Cohort. [PDF]
Pornsuthirat P +4 more
europepmc +1 more source
Critical care management of systemic mastocytosis: when every wasp is a killer bee [PDF]
core +1 more source
Management Strategy for Anaphylaxis in a Patient With Suspected or Confirmed Mastocytosis: A Case Report. [PDF]
Smoluchowski K +3 more
europepmc +1 more source
Hereditary Alpha-Tryptasemia and Mastocytosis: What We Know and What We Need To Learn. [PDF]
Rama TA, Gulen T.
europepmc +1 more source
Reconsidering cytoreductive therapy in high-risk pediatric mastocytosis: From diffuse cutaneous to smoldering systemic disease. [PDF]
Giavina-Bianchi M +5 more
europepmc +1 more source
Aggressive Systemic Mastocytosis Presenting as Diffuse Osteoblastic Bone Disease: A Diagnostic Pitfall Mimicking Metastatic Cancer. [PDF]
Melício A +4 more
europepmc +1 more source
Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis. [PDF]
Pongdee T +17 more
europepmc +1 more source
Comparative Analysis of Pediatric and Adult Mastocytosis: Clinical Presentation, Triggers, and Treatment Patterns from a Tertiary Care Registry. [PDF]
NoorSaeed SM +10 more
europepmc +1 more source

